NCT04857138
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04857138
Title A Study to Evaluate Safety, Pharmacokinetics and Anti-Tumor Activity of RO7300490, as Single Agent or in Combination With Atezolizumab in Participants With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR | FRA | ESP | DNK

Facility Status City State Zip Country Details
Rigshospitalet; Fase 1 Enhed - Onkologi København Ø 2100 Denmark Details
Gustave Roussy Villejuif 94805 France Details
Seoul National University Hospital Seoul 03080 South Korea Details
Asan Medical Center Seoul 05505 South Korea Details
Clinica Universitaria de Navarra; Servicio de Oncologia Pamplona Navarre 31008 Spain Details
Vall d?Hebron Institute of Oncology (VHIO), Barcelona Barcelona 08035 Spain Details
Clinica Universidad de Navarra Madrid; Servicio de Oncología Madrid 28027 Spain Details
START Madrid-FJD, Hospital Fundacion Jimenez Diaz Madrid 28040 Spain Details
Western General Hospital; Edinburgh Cancer Center Edinburgh EH4 2XU United Kingdom Details
Guys and St Thomas Hospital; OHCT Clinical Trials London SE1 9RT United Kingdom Details
Christie Hospital NHS Trust; Experimental Cancer Medicine Team Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field